Association between sacubitril/valsartan initiation and real‐world health status trajectories over 18 months in heart failure with reduced ejection fraction

Abstract Aims Improving the health status (symptoms, function, and quality of life) of patients with heart failure with reduced ejection fraction (HFrEF) is a primary treatment goal. Angiotensin receptor neprilysin inhibitors (ARNI) improve short‐term health status in clinical practice, but the sust...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Merrill Thomas, Yevgeniy Khariton, Gregg C. Fonarow, Suzanne V. Arnold, Larry Hill, Michael E. Nassif, Paul S. Chan, Javed Butler, Laine Thomas, Adam D. DeVore, Adrian F. Hernandez, Nancy M. Albert, J. Herbert Patterson, Fredonia B. Williams, John A. Spertus
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Oxford University Press 2021-08-01
Σειρά:	ESC Heart Failure
Θέματα:	Heart failure reduced ejection fraction Quality of life Health status Angiotensin‐neprilysin inhibitor
Διαθέσιμο Online:	https://doi.org/10.1002/ehf2.13298
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!